Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2012
11/13/2012US8309560 Methods and compositions for ameliorating the undesirable effects of chemotherapy
11/13/2012US8309559 (EN) substituted 2-amino-3-sulfonyl-pyrazolo[1,5-A] pyrimidines/antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof
11/13/2012US8309552 Immunomodulating heterocyclic compounds
11/13/2012US8309551 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders
11/13/2012CA2569993C Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles
11/08/2012WO2012151562A1 Combination pharmaceutical compositions and uses thereof
11/08/2012WO2012151525A1 Novel compounds as modulators of protein kinases
11/08/2012WO2012151512A2 Bromodomain inhibitors and uses thereof
11/08/2012WO2012151343A1 Pentylenetetrazole derivatives
11/08/2012WO2012151195A1 Hepatitis c virus inhibitors
11/08/2012WO2012150866A1 Phosphoribosyltransferase inhibitors and uses thereof
11/08/2012WO2012150328A1 Process for the production of sitagliptin
11/08/2012WO2012150305A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO- DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES
11/08/2012WO2012149689A1 New process for extracting chlorhematin from anymal blood
11/08/2012WO2012093809A3 New bicyclic compound for modulating g protein-coupled receptors
11/08/2012WO2012092411A3 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
11/08/2012WO2012092409A3 Macrocyclic hepatitis c serine protease inhibitors
11/08/2012US20120283447 Method for producing nanoparticles
11/08/2012US20120283437 Organic Electronic Device Comprising an Organic Semiconducting Material
11/08/2012US20120283430 System and Method for Fluoroalkylated Fluorophthalocyanines With Aggregating Properties and Catalytic Driven Pathway for Oxidizing Thiols
11/08/2012US20120283287 Certain chemical entities, compositions, and methods
11/08/2012US20120283280 Imidazotetrazinone-based combi-molecules
11/08/2012US20120283277 Inhibitors of bruton's tyrosine kinase
11/08/2012US20120283276 Inhibitors of bruton's tyrosine kinase
11/08/2012US20120283249 Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
11/08/2012US20120283248 Composition and method for treating cognitive impairments in down syndrom subjects
11/08/2012US20120283241 Imidazopyridazinecarbonitriles useful as kinase inhibitors
11/08/2012DE102011075399A1 New substituted imidazopyrid(az)ine compounds are soluble guanylate cyclase stimulators, useful to treat e.g. heart disease, angina pectoris, hypertension, pulmonary hypertension, ischemia, vascular disease or renal insufficiency
11/08/2012DE102011075398A1 Substituierte Imidazopyridazine und ihre Verwendung Substituted Imidazopyridazine and their use
11/08/2012CA2836769A1 Combination pharmaceutical compositions and uses thereof
11/08/2012CA2835105A1 Hepatitis c virus inhibitors
11/08/2012CA2835018A1 Pentylenetetrazole derivatives
11/08/2012CA2833935A1 Novel compounds as modulators of protein kinases
11/08/2012CA2833509A1 Novel antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]benzo- diazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives
11/07/2012EP2521196A1 Organic electroluminescent element
11/07/2012EP2520577A1 Pyrazolo[1,5-a]pyrimidine compounds as CB1 receptor antagonists
11/07/2012EP2520575A1 1,3,4-oxadiazole-2-carboxamide compound
11/07/2012EP2520574A1 Amiloride analogues substituted on the cyclic guanidine moiety as ENaC blockers for treating respiratory diseases
11/07/2012EP2519526A1 Tricyclic compounds for use as kinase inhibitors
11/07/2012EP2519525A2 Substituted pyrrolo-aminopyrimidine compounds
11/07/2012EP2519524A1 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
11/07/2012EP2519519A2 Substituted naphthalenyl-pyrimidine compounds
11/07/2012CN202519044U Device for co-producing synthesis ammonia and urotropine
11/07/2012CN1871240B Pyrrolopyrimidine thion derivatives
11/07/2012CN102770435A Pyrazolopyrimidine compounds and their use as PDE10 inhibitors
11/07/2012CN102770434A Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor
11/07/2012CN102770429A Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
11/07/2012CN102770181A Novel antiviral compounds
11/07/2012CN102766145A Fluorinated aza imidazolone derivative, synthesis method and application thereof
11/07/2012CN102766144A Preparation method of indolo[1,2-]quinazoline compound
11/07/2012CN102766142A Lactam compounds useful as protein kinase inhibitors
11/07/2012CN102766095A Preparation method of electron-deficient group-containing multi-substituted pyrazole derivative
11/07/2012CN102125549B Dihydroporphin photosensitizer as well as preparation method and application thereof
11/07/2012CN102123710B Bicyclic triazole derivatives for treating tumors
11/07/2012CN102068428B Dihydroporphin photosensitizer and preparation and application thereof
11/07/2012CN102020648B 3-aryl-6-aryl-[1,2,4] triazol [4,3-b] pyridazine taken as cell proliferation inhibitor and application of cell proliferation inhibitor
11/07/2012CN102017220B Compound for organic electric field light-emitting element and organic electric field light-emitting element
11/07/2012CN101827848B 2- [ (2-{phenylamino}-1H-pyrrolo [2, 3-d] pyrimidin-4-yl) amino] benzamide derivatives as iIGF-1R inhibitors for the treatment of cancer
11/07/2012CN101687886B Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
11/07/2012CN101580506B 1-3 generation arylene ether dendritic phthalocyanine complex and polymer nano-particle thereof
11/07/2012CN101563350B Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5-a]pyrimidin-7-yl]-phenyl-N-methyl-acetamide
11/07/2012CN101242839B Azaindazole compounds and methods of use
11/06/2012US8304536 Phthalocyanine compound
11/06/2012US8304418 Pyrazolopyrimidinone kinase inhibitor
11/06/2012US8304417 Crystalline forms of 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012US8304283 Method for producing organic electronic device including converting a precursor for a semiconductor layer
11/06/2012CA2563269C Process for producing cyclic n-hydroxy imide compounds
11/06/2012CA2558195C 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines
11/06/2012CA2551178C Polycyclic agents for the treatment of respiratory syncytial virus infections
11/06/2012CA2495685C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
11/01/2012WO2012149157A2 Heterocyclic compounds for the inhibition of pask
11/01/2012WO2012148775A1 Bicyclic pyridazine compounds as pim inhibitors
11/01/2012WO2012148246A2 A preparation method of sitagliptin
11/01/2012WO2012147952A1 Cathode catalyst for air secondary battery and air secondary battery
11/01/2012WO2012147890A1 Novel azole derivative
11/01/2012WO2012147750A1 Imidazole derivative
11/01/2012WO2012146667A1 Imidazopyridine derivatives as pi3k inhibitors
11/01/2012WO2012146666A1 Pyrrolotriazinone derivatives as pi3k inhibitors
11/01/2012WO2012146644A1 Salt of an inhibitor of phosphodiesterase 10 enzyme
11/01/2012WO2012146552A1 Pyrazolidin-3-one derivatives
11/01/2012WO2012146318A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl] - 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
11/01/2012WO2012145981A1 Adamantane or adamantane-like compounds as antitumor agents
11/01/2012US20120277434 Methods for synthesizing quinolinone compounds
11/01/2012US20120277428 New coupling agents for peptide synthesis
11/01/2012US20120277425 Tetrahydropteridines useful as inhibitors of protein kinases
11/01/2012US20120277420 Refined routes to chlorin building blocks
11/01/2012US20120277255 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277254 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277248 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
11/01/2012US20120277243 Pyrazolidin-3-one derivatives
11/01/2012US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/01/2012US20120277238 Pharmaceutical composition containing fused hetero-ring derivative
11/01/2012US20120277228 Novel Azaheterocyclic Compounds
11/01/2012US20120277225 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277224 Heterocyclic compounds for the inhibition of pask
11/01/2012US20120277217 Imidazole Derivatives as IDO Inhibitors
11/01/2012US20120277215 Organic Compounds
11/01/2012US20120277214 Tricyclopyrazole derivatives
11/01/2012US20120277205 Derivatives of n-[(1h-pyrazol-1-yl)aryl]-1h-indole or 1h-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 573